You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
Trading
Institutions
Fees
Promotions
FAQ
Education
Download
About us
Hong Kong
uSMART
EN
Login/Register
Market News

Market News

HomeMarket NewsDetails

《大行報告》大摩下調華潤醫藥(03320.HK)目標價至5.5元 評級「與大市同步」

阿思達克 09-14 10:01
摩根士丹利發表報告，下調華潤醫藥(03320.HK)股份目標價，由5.7元降至5.5元，評級維持「與大市同步」，並調整集團今年至2025年盈利預測，由降低12%至調高9%不等，以反映明年開始整合博雅生物製藥的銷售、顆粒藥銷售增長(更高銷售預測)，及銷售和市場推廣開支提高。
华润医药(03320.HK)
Relevant Stocks
华润医药(03320.HK)
Relevant Recommendation
Business Collaboration
Account Opening

Services

FeesFAQExclusive Trading Tools

About Us

OverviewContact UsMedia Center

Agreement Statement

DisclaimerPrivacy Statement
Contact Us
Customer Service Hotline︰+852 3018 4526
Email︰cs@usmarthk.com
Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong
WhatsApp︰+852 5989 2641
Join the Community：
uSMART-Facebook-Page
uSmart Securities Limited
is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Copyright © 2022 uSMART . All Rights Reserved.